225
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Curcumin reduces the expression of interleukin 1β and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease

, , ORCID Icon, , &
Pages 297-302 | Received 26 Dec 2017, Accepted 15 Apr 2018, Published online: 28 May 2018

References

  • Gul A. Pathogenesis of Behcet's disease: autoinflammatory features and beyond. Semin Immunopathol. 2015;37:413–418.
  • Mazzoccoli G, Matarangolo A, Rubino R, et al. Behcet syndrome: from pathogenesis to novel therapies. Clin Exp Med. 2016;16:1–12.
  • Tugal-Tutkun I. Behçet's uveitis. Middle East Afr J Ophthalmol. 2009;16:219–224.
  • Zhou ZY, Chen SL, Shen N, Lu Y. Cytokines and Behcet's disease. Autoimmun Rev. 2012;11:699–704.
  • Davies LC, Jenkins SJ, Allen JE, et al. Tissue-resident macrophages. Nat Immunol. 2013;14:986–995.
  • Laria A, Lurati A, Marrazza M, et al. The macrophages in rheumatic diseases. J Inflamm Res. 2016;9:1–11.
  • Taylor J, Glenny AM, Walsh T, et al. Interventions for the management of oral ulcers in Behcet's disease. Cochrane Database Syst Rev. 2014;9:CD011018.
  • Kaklamani VG, Kaklamanis PG. Treatment of Behcet's disease–an update. Semin Arthritis Rheum. 2001;30:299–312.
  • Gautam SC, Gao X, Dulchavsky S. Immunomodulation by curcumin. Adv Exp Med Biol. 2007;595:321–341.
  • Perrone D, F, Ardito G, Giannatempo M, et al. Biological and therapeutic activities, and anticancer properties of curcumin. Exp Ther Med. 2015;10:1615–1623.
  • Alok A, Singh ID, Singh S, et al. Curcumin -- pharmacological actions and its role in oral submucous fibrosis: a review. J Clin Diagn Res. 2015;9:1–3.
  • Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013;169:1672–1692.
  • Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 1995;49:1551–1556.
  • Zhou Y, Zhang T, Wang X, et al. Curcumin Modulates macrophage polarization through the inhibition of the toll-like receptor 4 expression and its signaling pathways. Cell Physiol Biochem. 2015;36:631–641.
  • Singh S, Aggarwal BB. Activation of transcription factor NF-kappa. J Biol Chem. 1995;270:24995–25000.
  • Xu YX, Pindolia KR, Janakiraman N, et al. Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol. 1997;11:49–62.
  • Gao S, Zhou J, Liu N, et al. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. J Mol Cell Cardiol. 2015;85:131–139.
  • Bright JJ. Curcumin and autoimmune disease. Adv Exp Med Biol. 2007;595:425–451.
  • Funk JL, Oyarzo JN, Frye JB, et al. Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis. J Nat Prod. 2006;69:351–355.
  • Deodhar SD, Sethi R, Srimal RC. Preliminary study on antirheumatic activity of curcumin (diferuloyl methane). Indian J Med Res. 1980;71:632–634.
  • Henrotin Y, Priem F, Mobasheri A. Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springerplus. 2013;2:56.
  • Handono K, Pratama MZ, Endharti AT, et al. Treatment of low doses curcumin could modulate Th17/Treg balance specifically on CD4+ T cell cultures of systemic lupus erythematosus patients. Cent Eur J Immunol. 2015;4:461–469.
  • International Criteria for Behcet's Disease (ICBD). Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s disease. Lancet. 1990;335:1078–1080.
  • Rezaiemanesh A, Mahmoudi M, Amirzargar AA, et al. Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23. Mod Rheumatol. 2017;27:862–867.
  • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108.
  • Alpsoy E. Behcet's disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43:620–632.
  • Direskeneli H. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? Rheumatology (Oxford). 2006;45:1461–1465.
  • Park UC, Kim TW, Yu HG. Immunopathogenesis of ocular Behcet's disease. J Immunol Res. 2014;2014:653539.
  • Saleh Z, Arayssi T. Update on the therapy of Behcet disease. Ther Adv Chronic Dis. 2014;5:112–134.
  • Nagpal M, Sood S. Role of curcumin in systemic and oral health: an overview. J Nat Sc Biol Med. 2013;4:3–7.
  • Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41:40–59.
  • Akdeniz N, Esrefoglu M, Keles MS, et al. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease. Ann Acad Med Singapore. 2004;33:596–599.
  • Bardak Y, Aridogan BC. The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behcet's disease with ocular involvement. Ocul Immunol Inflamm. 2004;12:53–58.
  • Mege JL, Dilsen N, Sanguedolce V, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behcet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol. 1993;20:1544–1549.
  • Tourkina E, Gooz P, Oates JC, et al. Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol. 2004;31:28–35.
  • Bosman B. Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol Physiol. 1994;7:324–334.
  • Deshmukh RA, Bagewadi AS. Comparison of effectiveness of curcumin with triamcinolone acetonide in the gel form in treatment of minor recurrent aphthous stomatitis: a randomized clinical trial. Int J Pharma Investig. 2014;4:138–141.
  • Lim YS, Kwon SK, Park JH, et al. Enhanced mucosal healing with curcumin in animal oral ulcer model. Laryngoscope. 2016;126:E68–E73.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.